Izaak Tyson-Hirst

Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3

Fraser J. Scott, J. Sutton, S. Dancer, 2022, ACS infectious diseases.

Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection

Fraser J. Scott, F. Brombacher, R. Guler, 2022, The Journal of antimicrobial chemotherapy.